Drakt Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 8.95 M
as on 06-07-2024
- Company Age 31 Year, 7 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 0.55 M
as on 06-07-2024
- Satisfied Charges ₹ 7.10 Cr
as on 06-07-2024
- Revenue -24.43%
(FY 2019)
- Profit -233.20%
(FY 2019)
- Ebitda -40.50%
(FY 2019)
- Net Worth -5.63%
(FY 2019)
- Total Assets 19.23%
(FY 2019)
About Drakt Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.95 M.
The company currently has active open charges totaling ₹0.55 M. The company has closed loans amounting to ₹7.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kanchan Ghosal, Pabitra Chakraborty, Sanjoy Paul, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24232WB1993PTC058790
- Company No.
058790
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 1993
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
South 24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Drakt Pharmaceuticals Pvt Ltd offer?
Drakt Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Third Party Manufacturing Consultancy, Pharmaceutical Third Party Manufacturing, Ointment, Antacid Drugs, Carminative Enzyme Syrup, Multivitamin Syrup & Drops, Multivitamin Drops, Mineral Supplement, Zinc Gluconate, Common Disease Medicines.
Who are the key members and board of directors at Drakt Pharmaceuticals?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanchan Ghosal  | Director | 28-Sep-1994 | Current |
| Pabitra Chakraborty | Director | 12-May-1993 | Current |
| Sanjoy Paul | Director | 12-May-1993 | Current |
| Bibhas Saha | Director | 12-May-1993 | Current |
| Jiban Saha | Director | 28-Sep-1994 | Current |
| Swapan Roy | Director | 19-May-1998 | Current |
Financial Performance of Drakt Pharmaceuticals.
Drakt Pharmaceuticals Pvt Ltd, for the financial year ended 2019, experienced significant reduction in revenue, with a 24.43% decrease. The company also saw a substantial fall in profitability, with a 233.2% decrease in profit. The company's net worth dipped by a decrease of 5.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Drakt Pharmaceuticals?
In 2017, Drakt Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Drakt International Private LimitedActive 1 year 7 monthsPabitra Chakraborty, Sanjoy Paul and 2 more are mutual person
- Drakt Marketing Pvt. Ltd.Active 31 years 7 months
Sanjoy Paul, Bibhas Saha and 3 more are mutual person
- Jiban Kumar Saha Construction Private LimitedActive 15 years 10 months
Jiban Saha is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 09 Apr 2019 | ₹0.55 M | Open |
State Bank Of India Creation Date: 24 Sep 2011 | ₹1.54 Cr | Satisfied |
State Bank Of India Creation Date: 14 Sep 2007 | ₹1.54 Cr | Satisfied |
How Many Employees Work at Drakt Pharmaceuticals?
Drakt Pharmaceuticals has a workforce of 61 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Drakt Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drakt Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
